Cargando…

Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa

Pseudomonas aeruginosa may become multidrug-resistant (MDR) due to multiple inherited and acquired resistance mechanisms. The human gastrointestinal tract is known as a reservoir of P. aeruginosa and its resistance genes. In this study, we collected 76 intestinal carbapenem-resistant P. aeruginosa (...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yanyan, Qing, Yan, Chen, Jiawei, Liu, Congcong, Lu, Jiayue, Wang, Qi, Zhen, Shufang, Zhou, Hongwei, Huang, Ling, Zhang, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612150/
https://www.ncbi.nlm.nih.gov/pubmed/34817230
http://dx.doi.org/10.1128/Spectrum.01344-21
_version_ 1784603422069096448
author Hu, Yanyan
Qing, Yan
Chen, Jiawei
Liu, Congcong
Lu, Jiayue
Wang, Qi
Zhen, Shufang
Zhou, Hongwei
Huang, Ling
Zhang, Rong
author_facet Hu, Yanyan
Qing, Yan
Chen, Jiawei
Liu, Congcong
Lu, Jiayue
Wang, Qi
Zhen, Shufang
Zhou, Hongwei
Huang, Ling
Zhang, Rong
author_sort Hu, Yanyan
collection PubMed
description Pseudomonas aeruginosa may become multidrug-resistant (MDR) due to multiple inherited and acquired resistance mechanisms. The human gastrointestinal tract is known as a reservoir of P. aeruginosa and its resistance genes. In this study, we collected 76 intestinal carbapenem-resistant P. aeruginosa (CRPA) strains from clinical inpatients admitted to our hospital from 2014 to 2019, together with their medical data. We aim to analyze the clinical risk factors associated with CRPA infection and its molecular features. We found that the prevalence of CRPA in P. aeruginosa strains was 41.3% (95% confidence interval [CI], 34.1 to 48.8%). We also identified four variables associated with intestinal CRPA positivity, prior antibiotic exposure to aminoglycosides or carbapenems, underlying diabetes mellitus, and extraintestinal P. aeruginosa isolation. bla(KPC-2) is the only detected carbapenemase gene, accounting for 21.1% of CRPA strains. The genetic environment showed that the bla(KPC-2) gene was flanked immediately by ISKpn8 and ISKpn6 and several other mobile elements further upstream or downstream. Four sequence types (STs) were identified, with ST463 as the dominant sequence type. In conclusion, screening for P. aeruginosa colonization upon hospital admission could reduce the risk of P. aeruginosa infection and spread of CRPA in the hospital. IMPORTANCE Pseudomonas aeruginosa may become multidrug-resistant (MDR) due to multiple inherited and acquired resistance mechanisms. The human gastrointestinal tract is known as a reservoir of P. aeruginosa and its resistance genes. Risk factor analysis and molecular epidemiology are critical for preventing their potential dissemination. Here, we identified four risk factors associated with intestinal CRPA—prior antibiotic exposure to aminoglycosides or carbapenems, underlying diabetes mellitus, and extraintestinal P. aeruginosa isolation. Further, we found similar genetic environments with several mobile elements surrounding the bla(KPC) gene, a carbapenemase gene only detected in intestinal CRPA strains in this study. These findings are of significant public health importance, as the information will facilitate the control of the emergence and spread of CRPA.
format Online
Article
Text
id pubmed-8612150
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-86121502021-11-29 Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa Hu, Yanyan Qing, Yan Chen, Jiawei Liu, Congcong Lu, Jiayue Wang, Qi Zhen, Shufang Zhou, Hongwei Huang, Ling Zhang, Rong Microbiol Spectr Research Article Pseudomonas aeruginosa may become multidrug-resistant (MDR) due to multiple inherited and acquired resistance mechanisms. The human gastrointestinal tract is known as a reservoir of P. aeruginosa and its resistance genes. In this study, we collected 76 intestinal carbapenem-resistant P. aeruginosa (CRPA) strains from clinical inpatients admitted to our hospital from 2014 to 2019, together with their medical data. We aim to analyze the clinical risk factors associated with CRPA infection and its molecular features. We found that the prevalence of CRPA in P. aeruginosa strains was 41.3% (95% confidence interval [CI], 34.1 to 48.8%). We also identified four variables associated with intestinal CRPA positivity, prior antibiotic exposure to aminoglycosides or carbapenems, underlying diabetes mellitus, and extraintestinal P. aeruginosa isolation. bla(KPC-2) is the only detected carbapenemase gene, accounting for 21.1% of CRPA strains. The genetic environment showed that the bla(KPC-2) gene was flanked immediately by ISKpn8 and ISKpn6 and several other mobile elements further upstream or downstream. Four sequence types (STs) were identified, with ST463 as the dominant sequence type. In conclusion, screening for P. aeruginosa colonization upon hospital admission could reduce the risk of P. aeruginosa infection and spread of CRPA in the hospital. IMPORTANCE Pseudomonas aeruginosa may become multidrug-resistant (MDR) due to multiple inherited and acquired resistance mechanisms. The human gastrointestinal tract is known as a reservoir of P. aeruginosa and its resistance genes. Risk factor analysis and molecular epidemiology are critical for preventing their potential dissemination. Here, we identified four risk factors associated with intestinal CRPA—prior antibiotic exposure to aminoglycosides or carbapenems, underlying diabetes mellitus, and extraintestinal P. aeruginosa isolation. Further, we found similar genetic environments with several mobile elements surrounding the bla(KPC) gene, a carbapenemase gene only detected in intestinal CRPA strains in this study. These findings are of significant public health importance, as the information will facilitate the control of the emergence and spread of CRPA. American Society for Microbiology 2021-11-24 /pmc/articles/PMC8612150/ /pubmed/34817230 http://dx.doi.org/10.1128/Spectrum.01344-21 Text en Copyright © 2021 Hu et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Hu, Yanyan
Qing, Yan
Chen, Jiawei
Liu, Congcong
Lu, Jiayue
Wang, Qi
Zhen, Shufang
Zhou, Hongwei
Huang, Ling
Zhang, Rong
Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa
title Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa
title_full Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa
title_fullStr Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa
title_full_unstemmed Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa
title_short Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa
title_sort prevalence, risk factors, and molecular epidemiology of intestinal carbapenem-resistant pseudomonas aeruginosa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612150/
https://www.ncbi.nlm.nih.gov/pubmed/34817230
http://dx.doi.org/10.1128/Spectrum.01344-21
work_keys_str_mv AT huyanyan prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa
AT qingyan prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa
AT chenjiawei prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa
AT liucongcong prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa
AT lujiayue prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa
AT wangqi prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa
AT zhenshufang prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa
AT zhouhongwei prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa
AT huangling prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa
AT zhangrong prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa